Dosimetric consideration of individual 125I source strength measurement and a large-scale comparison of that measured with a nominal value in permanent prostate implant brachytherapy

Radiation Medicine - Medical Imaging and Radiation Oncology

Volumn 24, Issue 10, 2006, Pages 675-679

  Takahashi, Yutaka ^a   Ito, Akira ^a   Sumida, Iori ^a   Kozuka, Takuyo ^a   Gomi, Kotaro ^a   Nose, Takayuki ^a   Ito, Teruo ^a   Yamashita, Takashi ^a  

^a CANCER INSTITUTE   (Japan)

Author keywords

125I seed; Measurement; Permanent prostate implant brachytherapy; Source strength; Well type ionization chamber

Indexed keywords

IODINE 125;

ARTICLE; BRACHYTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DOSIMETRY; HUMAN; IONIZATION CHAMBER; PROSTATE; RADIOSENSITIVITY;

BRACHYTHERAPY; HUMANS; IODINE RADIOISOTOPES; MALE; PROSTATIC NEOPLASMS; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED;

EID: 33846845198     PISSN: 02882043     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11604-006-0088-0     Document Type: Article

References (8)

1. Lee PC, Starr SJ, Zuhlke K, Moran BJ. Comparison of a proposed five-seed assay method with the single-seed and batch assay methods for I-125 seeds in ultrasound-guided prostate implants. Radiat Oncol Invest 1999;7:374-81.
2. 103Pd air-kerma strengths. Med Phys 1995;22:1495-7.
3. DeWerd LA. Brachytherapy dosimetric assessment: source calibration. In: Thomadsen B (ed) Categorical course in brachytherapy physics syllabus. Oak Brook, IL: Radiological Society of North America; 1997. p. 143-53.
4. Hanson WF, Shalek RJ, Kennedy P. Dosimetry quality assurance in the U.S. from the experience of the Radiological Physics Center. In: Starkschall G, Horton J (eds) Proceedings of an American College of Medical Physics Symposium: quality assurance in radiotherapy physics. Madison, WI: Medical Physics Publishing; 1991. p. 255-82.
5. Yu Y, Zuofeng L, Mellenberg DE, Mellenberg DE, Nath R, Schell MC, et al. Permanent prostate seed implant brachytherapy: report of the American Association of Physicists in Medicine Task Group No. 64. Med Phys 1999;26:2054-76.
6. Nath R, Anderson L, Jones D, Ling C, Loevinger R, Williamson J, et al. Specification of brachytherapy source strength: report of AAPM Task Group No. 32. Med Phys 1991;18:439-48.
7. Furutani S, Ikushima H, Ozaki K, Oita M, Sasaki M, Takegawa Y, et al. Quality assurance of I-125 seed permanent implant therapy using a self-color developing reflection-type dosimetry sheet film. Radiat Med 2005;23:474-7.
8. DeWerd LA, Huq MS, Das IJ, Ibbott GS, Hanson WF, Slowey TW, et al. Procedures for establishing and maintaining consistent air-kerma strength standards for low-energy, photon-emitting brachytherapy sources: recommendations of the Calibration Laboratory Accreditation Subcommittee of the American Association of Physicists in Medicine. Med Phys 2004;31:675-81.